MATINAS BIOPHARMA HOLDINGS, INC. Prepaid Expense, Current
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) had Prepaid Expense, Current of $1.39 million as of 2019-09-30, per its 10-Q filed 2019-11-13.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:PrepaidExpenseCurrent · last filed 2019-11-13
- 2019-09-30: Prepaid Expense, Current $1.39M.
- 2019-06-30: Prepaid Expense, Current $494.65K.
- 2019-03-31: Prepaid Expense, Current $391.03K.
- 2018-12-31: Prepaid Expense, Current $538.65K.
| Period end | Prepaid Expense, Current |
|---|---|
| 2019-09-30 | $1.39M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $494.65K 10-Q · filed 2019-08-13 |
| 2019-03-31 | $391.03K 10-Q · filed 2019-05-13 |
| 2018-12-31 | $538.65K 10-Q · filed 2019-11-13 |
| 2018-09-30 | $692.40K 10-Q · filed 2018-11-09 |
| 2018-06-30 | $249.75K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $475.27K 10-Q · filed 2018-05-09 |
| 2017-12-31 | $502.03K 10-K · filed 2019-04-01 |
| 2017-09-30 | $1.02M 10-Q · filed 2017-11-14 |
| 2016-12-31 | $304.43K 10-K · filed 2018-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |